Stratification of Postremission Therapy in Adult Acute Myeloid Leukemia According to the Karyotype — Preliminary Results of the Multicenter Treatment Trial AML HD93
- 1 January 1998
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994
- Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemiaCancer Genetics and Cytogenetics, 1993
- A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.Journal of Clinical Oncology, 1992
- Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AMLCancer Genetics and Cytogenetics, 1992
- Trisomy 13: a new recurring chromosome abnormality in acute leukemiaBlood, 1990
- Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study GroupBlood, 1990
- Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemiaBlood, 1989